bococizumab (PF-04950615)

bococizumab · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for bococizumab (PF-04950615), covering 2019-02-08 to 2019-02-08. Get the full timeline:

Most recent: Clinical Trial Update: Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects [Phase 2]